nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—CYP19A1—Paclitaxel—ovarian cancer	0.402	1	CbGbCtD
Drostanolone—CYP19A1—follicular fluid—ovarian cancer	0.129	0.308	CbGeAlD
Drostanolone—CYP19A1—corpus luteum—ovarian cancer	0.0742	0.177	CbGeAlD
Drostanolone—CYP19A1—ovarian follicle—ovarian cancer	0.0581	0.139	CbGeAlD
Drostanolone—AR—oviduct—ovarian cancer	0.0226	0.0539	CbGeAlD
Drostanolone—AR—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.00979	0.059	CbGpPWpGaD
Drostanolone—AR—myometrium—ovarian cancer	0.00723	0.0173	CbGeAlD
Drostanolone—SHBG—endometrium—ovarian cancer	0.00709	0.0169	CbGeAlD
Drostanolone—SHBG—gonad—ovarian cancer	0.00657	0.0157	CbGeAlD
Drostanolone—SHBG—uterus—ovarian cancer	0.00653	0.0156	CbGeAlD
Drostanolone—SHBG—female reproductive system—ovarian cancer	0.00587	0.014	CbGeAlD
Drostanolone—AR—Nuclear Receptors—NR5A1—ovarian cancer	0.00586	0.0354	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.00579	0.0349	CbGpPWpGaD
Drostanolone—CYP19A1—endometrium—ovarian cancer	0.00574	0.0137	CbGeAlD
Drostanolone—AR—epithelium—ovarian cancer	0.00567	0.0135	CbGeAlD
Drostanolone—CYP19A1—Ovarian Infertility Genes—INHA—ovarian cancer	0.00563	0.034	CbGpPWpGaD
Drostanolone—AR—uterine cervix—ovarian cancer	0.00562	0.0134	CbGeAlD
Drostanolone—SHBG—bone marrow—ovarian cancer	0.00554	0.0132	CbGeAlD
Drostanolone—AR—decidua—ovarian cancer	0.00536	0.0128	CbGeAlD
Drostanolone—SHBG—female gonad—ovarian cancer	0.00534	0.0128	CbGeAlD
Drostanolone—CYP19A1—gonad—ovarian cancer	0.00533	0.0127	CbGeAlD
Drostanolone—SHBG—vagina—ovarian cancer	0.00531	0.0127	CbGeAlD
Drostanolone—CYP19A1—uterus—ovarian cancer	0.00529	0.0126	CbGeAlD
Drostanolone—AR—endometrium—ovarian cancer	0.00509	0.0121	CbGeAlD
Drostanolone—CYP19A1—FSH signaling pathway—AREG—ovarian cancer	0.00477	0.0287	CbGpPWpGaD
Drostanolone—CYP19A1—female reproductive system—ovarian cancer	0.00476	0.0114	CbGeAlD
Drostanolone—SHBG—testis—ovarian cancer	0.00474	0.0113	CbGeAlD
Drostanolone—AR—gonad—ovarian cancer	0.00472	0.0113	CbGeAlD
Drostanolone—AR—uterus—ovarian cancer	0.00469	0.0112	CbGeAlD
Drostanolone—AR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00463	0.0279	CbGpPWpGaD
Drostanolone—CYP19A1—female gonad—ovarian cancer	0.00433	0.0103	CbGeAlD
Drostanolone—AR—female reproductive system—ovarian cancer	0.00421	0.0101	CbGeAlD
Drostanolone—CYP19A1—testis—ovarian cancer	0.00384	0.00917	CbGeAlD
Drostanolone—AR—female gonad—ovarian cancer	0.00383	0.00915	CbGeAlD
Drostanolone—AR—vagina—ovarian cancer	0.00381	0.0091	CbGeAlD
Drostanolone—Trilostane—ESR1—ovarian cancer	0.00371	0.278	CrCbGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—BCL9—ovarian cancer	0.0037	0.0223	CbGpPWpGaD
Drostanolone—AR—testis—ovarian cancer	0.0034	0.00812	CbGeAlD
Drostanolone—CYP19A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00319	0.0193	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.00317	0.0191	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00304	0.0183	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.00302	0.0182	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PGR—ovarian cancer	0.00292	0.0176	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—PGR—ovarian cancer	0.00288	0.0174	CbGpPWpGaD
Drostanolone—CYP19A1—lymph node—ovarian cancer	0.00278	0.00665	CbGeAlD
Drostanolone—SHBG—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.00262	0.0158	CbGpPWpGaD
Drostanolone—AR—lymph node—ovarian cancer	0.00246	0.00588	CbGeAlD
Drostanolone—SHBG—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.00242	0.0146	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00231	0.0139	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CCND2—ovarian cancer	0.0023	0.0139	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—PARP1—ovarian cancer	0.00229	0.0138	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.00214	0.0129	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—BRCA1—ovarian cancer	0.00208	0.0125	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00207	0.0125	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—SOD1—ovarian cancer	0.00197	0.0119	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.00192	0.0116	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00185	0.0112	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00183	0.0111	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00178	0.0107	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—ovarian cancer	0.00176	0.0106	CbGpPWpGaD
Drostanolone—Estradiol—CYP1B1—ovarian cancer	0.00173	0.13	CrCbGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—BRCA1—ovarian cancer	0.0016	0.00964	CbGpPWpGaD
Drostanolone—Progesterone—PGR—ovarian cancer	0.00157	0.118	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00157	0.00945	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—ESR1—ovarian cancer	0.00156	0.0094	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00148	0.00894	CbGpPWpGaD
Drostanolone—Progesterone—CYP1B1—ovarian cancer	0.00147	0.11	CrCbGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00146	0.00882	CbGpPWpGaD
Drostanolone—Testosterone—CYP1B1—ovarian cancer	0.00139	0.104	CrCbGaD
Drostanolone—AR—FOXA1 transcription factor network—ESR1—ovarian cancer	0.00139	0.00836	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ovarian cancer	0.00129	0.00776	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—MTOR—ovarian cancer	0.00128	0.0077	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00123	0.00743	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.0012	0.00725	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—BRCA1—ovarian cancer	0.00118	0.00713	CbGpPWpGaD
Drostanolone—Estradiol—ESR1—ovarian cancer	0.00117	0.0876	CrCbGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.00113	0.00684	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.00106	0.00639	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.00105	0.00631	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CCNE1—ovarian cancer	0.00104	0.00624	CbGpPWpGaD
Drostanolone—Progesterone—ESR1—ovarian cancer	0.000992	0.0743	CrCbGaD
Drostanolone—AR—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.000981	0.00592	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.000975	0.00588	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—ovarian cancer	0.000964	0.00582	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—MAPK3—ovarian cancer	0.000943	0.00569	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000943	0.00569	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.000934	0.00563	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000911	0.00549	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000904	0.00545	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—MAPK1—ovarian cancer	0.000897	0.00541	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—CDKN1B—ovarian cancer	0.000894	0.00539	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000851	0.00513	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000826	0.00498	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CAV1—ovarian cancer	0.000819	0.00494	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—ovarian cancer	0.000813	0.0049	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.00081	0.00489	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.0008	0.00483	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000778	0.00469	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000774	0.00467	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.00075	0.00452	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000749	0.00452	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ovarian cancer	0.000748	0.00451	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—STAT3—ovarian cancer	0.000736	0.00444	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	0.00072	0.00434	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000711	0.00429	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.0007	0.00422	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CCND1—ovarian cancer	0.000692	0.00418	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CTNNB1—ovarian cancer	0.000686	0.00414	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000685	0.00413	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000666	0.00402	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.000662	0.00399	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000642	0.00387	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	0.000638	0.00385	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	0.000636	0.00384	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00063	0.0038	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000602	0.00363	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	0.000598	0.00361	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.00058	0.0035	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000562	0.00339	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000562	0.00339	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	0.000557	0.00336	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	0.000552	0.00333	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000552	0.00333	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	0.000541	0.00326	CbGpPWpGaD
Drostanolone—AR—Gene Expression—WDR77—ovarian cancer	0.000541	0.00326	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000517	0.00312	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CCND1—ovarian cancer	0.000512	0.00309	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CTNNB1—ovarian cancer	0.000507	0.00306	CbGpPWpGaD
Drostanolone—Estradiol—ABCB1—ovarian cancer	0.000496	0.0372	CrCbGaD
Drostanolone—AR—Androgen receptor signaling pathway—PTEN—ovarian cancer	0.000494	0.00298	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000492	0.00297	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000457	0.00275	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.00045	0.00271	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	0.000447	0.0027	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000445	0.00268	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000443	0.00267	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—STAT3—ovarian cancer	0.000442	0.00266	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000428	0.00258	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TTF1—ovarian cancer	0.000424	0.00256	CbGpPWpGaD
Drostanolone—Progesterone—ABCB1—ovarian cancer	0.000421	0.0316	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000405	0.00244	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	0.000402	0.00242	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PGR—ovarian cancer	0.000399	0.0024	CbGpPWpGaD
Drostanolone—Testosterone—ABCB1—ovarian cancer	0.000398	0.0298	CrCbGaD
Drostanolone—CYP19A1—Metabolism—NME2—ovarian cancer	0.000389	0.00235	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000387	0.00233	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NR5A1—ovarian cancer	0.000385	0.00232	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	0.000385	0.00232	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000375	0.00226	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000371	0.00223	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000351	0.00211	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000344	0.00208	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000336	0.00202	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000335	0.00202	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000332	0.002	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00033	0.00199	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000324	0.00195	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000324	0.00195	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000322	0.00194	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000314	0.0019	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000307	0.00185	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000296	0.00179	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000292	0.00176	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000291	0.00176	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000289	0.00174	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000286	0.00172	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000285	0.00172	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000285	0.00172	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	0.000285	0.00172	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000278	0.00168	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000278	0.00168	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000275	0.00166	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000269	0.00162	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000269	0.00162	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000268	0.00162	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000263	0.00159	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000263	0.00159	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000252	0.00152	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYTB—ovarian cancer	0.000251	0.00151	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000249	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000245	0.00148	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000242	0.00146	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000231	0.0014	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000229	0.00138	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000226	0.00137	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000226	0.00137	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000223	0.00134	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000221	0.00133	CbGpPWpGaD
Drostanolone—AR—Gene Expression—YAP1—ovarian cancer	0.00022	0.00133	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPP1CC—ovarian cancer	0.000219	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BRIP1—ovarian cancer	0.000219	0.00132	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000218	0.00131	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000218	0.00131	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000214	0.00129	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000213	0.00128	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000206	0.00124	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000197	0.00119	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PGR—ovarian cancer	0.000192	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.00019	0.00115	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000189	0.00114	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000187	0.00112	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000183	0.0011	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PARP1—ovarian cancer	0.000178	0.00108	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.00016	0.000968	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00016	0.000964	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000155	0.000932	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—YAP1—ovarian cancer	0.000147	0.000887	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000146	0.000878	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPP2R1A—ovarian cancer	0.000145	0.000873	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000128	0.000772	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—FASN—ovarian cancer	0.00012	0.000723	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC5A5—ovarian cancer	0.000118	0.000711	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC2A1—ovarian cancer	0.000114	0.000687	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000112	0.000673	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—MYC—ovarian cancer	0.000111	0.000668	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP1B1—ovarian cancer	0.000109	0.000658	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ESR1—ovarian cancer	0.000102	0.000618	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	9.68e-05	0.000584	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.64e-05	0.000581	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCB1—ovarian cancer	8.99e-05	0.000542	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TYMS—ovarian cancer	8.83e-05	0.000533	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CAV1—ovarian cancer	7.12e-05	0.000429	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.8e-05	0.00041	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CG—ovarian cancer	6.48e-05	0.000391	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CD—ovarian cancer	5.7e-05	0.000344	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MAPK3—ovarian cancer	5.48e-05	0.000331	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MYC—ovarian cancer	5.33e-05	0.000321	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CB—ovarian cancer	4.97e-05	0.0003	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTEN—ovarian cancer	4.29e-05	0.000259	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—ovarian cancer	3.7e-05	0.000223	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CA—ovarian cancer	3.03e-05	0.000183	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—ovarian cancer	2.47e-05	0.000149	CbGpPWpGaD
